Evidence map›Paper›PMID 24160921›Full record

ArticleACS synthetic biology2013

Yeast oligo-mediated genome engineering (YOGE).

James E DiCarlo, Andrew J Conley, Merja Penttilä, Jussi Jäntti, Harris H Wang, George M Church

Abstract read
In one paragraph

Article in ACS synthetic biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Review
  2. Review
  3. The design and engineering of synthetic genomes.Nature reviews. Genetics · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Recombineering in Non-Model Bacteria.Current protocols · 2022
    Article
  13. Review
  14. Research progress of pathway and genome evolution in microbes.Synthetic and systems biotechnology · 2022
    Article
  15. Recent advances in construction and regulation of yeast cell factories.World journal of microbiology & biotechnology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Variation amongMicroorganisms · 2021
    Article
  20. Recombineering and MAGE.Nature reviews. Methods primers · 2021
    Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James E DiCarloDepartment of Genetics, Harvard Medical School , Boston, Massachusetts 02115, United States.
Andrew J Conley
Merja Penttilä
Jussi Jäntti
Harris H Wang
George M Church

Funding

Functional Metagenomic Reprogramming of the Human Microbiome through Mobilome EngDP5OD009172 · OD · HARVARD MEDICAL SCHOOL · PI WANG, HARRIS H · 2011 to 2015
$2.0M
NIH HHS 1DP5OD009172-01NIH HHS DP5 OD009172
6 · The paper itself

Abstract

High-frequency oligonucleotide-directed recombination engineering (recombineering) has enabled rapid modification of several prokaryotic genomes to date. Here, we present a method for oligonucleotide-mediated recombineering in the model eukaryote and industrial production host Saccharomyces cerevisiae , which we call yeast oligo-mediated genome engineering (YOGE). Through a combination of overexpression and knockouts of relevant genes and optimization of transformation and oligonucleotide designs, we achieve high gene-modification frequencies at levels that only require screening of dozens of cells. We demonstrate the robustness of our approach in three divergent yeast strains, including those involved in industrial production of biobased chemicals. Furthermore, YOGE can be iteratively executed via cycling to generate genomic libraries up to 10 (5) individuals at each round for diversity generation. YOGE cycling alone or in combination with phenotypic selections or endonuclease-based negative genotypic selections can be used to generate modified alleles easily in yeast populations with high frequencies.

Indexed as

Genetic EngineeringGenome, FungalOligonucleotidesRecombination, GeneticSaccharomyces cerevisiaeOligonucleotides

Identifiers

PMID24160921
PMCPMC4048964

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.